Using BCG to Protect Senior Citizens During the COVID-19 Pandemic

NCT04542330 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1700

Enrollment

OTHER

Sponsor class

Conditions

Covid19
Non-specific Effects of Vaccines
Heterologous Immunity
Morbidity
Immunosenescence
Vaccine Preventable Disease

Interventions

BIOLOGICAL: BCG-Denmark
BIOLOGICAL: Saline

Sponsor

Bandim Health Project

Collaborators

[object Object]
[object Object]
[object Object]